Happy anniversary to the 1,000 Healthy Elderly Study! 🎂 On this day last year, we included our very first participant (again). Today we’re at 196 re-inclusions, and on track to hit 200 by the end of the week. 💪 A special thank you today to our study nurse, Sofie Van de kerckhoven! 🥳 #CMNcohorts
Next up in our #CMNcohorts#CMNconsortia series, we spotlight a collaboration between the @sleegerslab.bsky.social and Dietmar Thal at KU Leuven: a post-mortem brain cohort, now paired with genetic characterization, and transcriptomic profiling underway.
World FTD Awareness Week kicked off right after World Alzheimer’s Day on Sunday, a timely reminder that while FTD is the second most common dementia, it’s not Alzheimer’s.
On #WorldAlzheimersDay, we’re reminded that progress is possible, and it’s powered by people. Every dataset, every partnership, every volunteer brings us closer to earlier detection and better treatments.
Thank you to our participants and collaborators. Hope moves forward together. 💜
When the gene is mapped, the work is far from done.
In this interview with Julie van der Zee, we talk why long-horizon science only delivers if relationships, records, and ethics are cared for as diligently as the data.
The Rademakers lab presents the most comprehensive analysis of DNA methylation patterns in FTLD-TDP to date, revealing that the molecular differences between disease subtypes run even deeper than previously recognized.
From 8 to 10 Sept, three hubs, at the University of Cambridge, VIB-University of Antwerp Center for Neurology, and Newcastle University, coded in sync on bioinformatics, math & computational biology.
Huge congratulations to Sebastiaan De Schepper on obtaining a prestigious ERC grant to launch PRIME-PD, a project uncovering how the immune system helps initiate and drive Parkinson’s disease. 🙌
We’ve built our strategy around consortia-driven science, where our own expertise plugs into global networks, and local patient data fuels international discovery. From genetics to biomarkers, there’s power in numbers. https://beakon.ghost.io/united-in-purpose/
Seppe De Schepper is looking forward to Katerina Akassoglou’s talk, whose "work on perivascular neuroimmunology is fascinating. It beautifully connects vascular changes to immune signaling and neurodegeneration.”
The study provides genetic + functional evidence across three families (8 individuals), linking COX18 (a Complex IV assembly factor) to predominantly peripheral neuropathy, with occasional CNS features.
As translational timelines are tightening and evidence demands keep rising, we’ve made biobanking a strategic priority. Read how we are building a biobank that’s shareable by default, analysis-ready by design, and fast to collaborate with. https://beakon.ghost.io/more-samples-less-friction/
“It's good to have worked in more than one place—you pick up good habits from each lab.” Read Trend's interview with our director Rosa Rademakers https://tinyurl.com/wnf4nytv
Next up in our cohorts and consortia series: Epi25 – Collaborative for Large-Scale Whole Genome Sequencing in Epilepsy 🧬
🧠 Epilepsy 🥼 >30,000 sequenced exomes, helpint to untangle the complex genetic causes 🌍 Over 200 partners from 40 cohorts around the world 📌 Sarah Weckhuysen 👉 epi-25.org
